BlackRock Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,305,810
Closed -$35.7M 3784
2015
Q1
$35.7M Sell
1,305,810
-284,814
-18% -$7.84M 0.04% 388
2014
Q4
$42M Sell
1,590,624
-106,709
-6% -$3.12M 0.04% 369
2014
Q3
$51.2M Sell
1,697,333
-28,518
-2% -$883K 0.05% 344
2014
Q2
$54.4M Buy
1,725,851
+410,556
+31% +$13M 0.05% 339
2014
Q1
$42.6M Sell
1,315,295
-74
-0% -$2.59K 0.04% 379
2013
Q4
$47.8M Buy
+1,315,369
New +$51.1M 0.05% 357
2013
Q3
Sell
-911
Closed -$34K 3632
2013
Q2
$34K Buy
+911
New +$36K ﹤0.01% 3220

Other funds holding MR

BlackRock Advisors's MR Position: Q2 2015 in Review

BlackRock Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 1,305,810 shares — an estimated $35.7M sold.

BlackRock Advisors first reported a position in MR in Q2 2013 and held it in 7 quarters. The position peaked at $54.4M in Q2 2014. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

  • BlackRock Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
  • BlackRock Advisors sold 1,305,810 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $35.7M.
  • BlackRock Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 7 quarters.
  • BlackRock Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $54.4M in Q2 2014.
  • 118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on BlackRock Advisors's 13F filing for Q2 2015, filed 7 Aug 2015.